Format

Send to

Choose Destination
See comment in PubMed Commons below
J Surg Oncol. 2010 Mar 15;101(4):315-20. doi: 10.1002/jso.21469.

Neoadjuvant therapy for pancreatic cancer: a current review.

Author information

1
Department of Surgery, Northwestern University/Feinberg School of Medicine, Chicago, Illinois, USA. abbottdaniel7@gmail.com

Abstract

The optimal therapy for pancreatic cancer continues to evolve. Neoadjuvant chemoradiation is a key component of current treatment regimens, and evaluation of previous treatment options will help guide future trials. Here the authors present a review of the current literature with discussion of future directions.

PMID:
20187063
DOI:
10.1002/jso.21469
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center